CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Cash Flows From Operating Activities:
Net (loss)	$ (860,293)	$ (1,858,450)
Adjustments to reconcile net (loss) / income to net cash used in operating activities:
Depreciation and amortization	194,215	291,404
Stock compensation expense	27,344
Common stock issued for services rendered	4,500	94,312
Common stock issued as make-whole payments on preferred stock	135,000	104,423
Change in fair value of derivative liabilities	(1,065,880)	(665,491)
Changes in operating assets and liabilities
Accounts payable and accrued expenses	823,734	(378,275)
Other current assets	43,351	150,565
Net Cash Used in Operating Activities	(698,029)	(2,261,512)
Cash Flows From Investing Activities:
Costs incurred for patents		(84,389)
Net Cash (Used in)/Provided By Investing Activities		(84,389)
Cash Flows From Financing Activities:
Proceeds from exercise of stock options	2,952	6,416
Net Cash Provided by Financing Activities	2,952	6,416
Effect of Exchange Rates on Cash	(7,717)	(4,078)
Net Decrease in Cash and Cash Equivalents	(702,794)	(2,343,563)
Cash and Cash Equivalents, Beginning of Period	749,965	3,269,489
Cash and Cash Equivalents, End of Period	$ 47,171	$ 925,926